HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus.

Abstract
Influenza A virus causes recurring seasonal epidemics and occasional influenza pandemics. Because of changes in envelope glycoprotein Ags, neutralizing Abs induced by inactivated vaccines provide limited cross-protection against new viral serotypes. However, prior influenza infection induces heterosubtypic immunity that accelerates viral clearance of a second strain, even if the external proteins are distinct. In mice, cross-protection can also be elicited by systemic immunization with the highly conserved internal nucleoprotein (NP). Both T lymphocytes and Ab contribute to such cross-protection. In this paper, we demonstrate that anti-NP IgG specifically promoted influenza virus clearance in mice by using a mechanism involving both FcRs and CD8(+) cells. Furthermore, anti-NP IgG rescued poor heterosubtypic immunity in B cell-deficient mice, correlating with enhanced NP-specific CD8 T cell responses. Thus, Ab against this conserved Ag has potent antiviral activity both in naive and in influenza-immune subjects. Such antiviral activity was not seen when mice were vaccinated with another internal influenza protein, nonstructural 1. The high conservation of NP Ag and the known longevity of Ab responses suggest that anti-NP IgG may provide a critically needed component of a universal influenza vaccine.
AuthorsMark W LaMere, Ho-Tak Lam, Amy Moquin, Laura Haynes, Frances E Lund, Troy D Randall, Denise A Kaminski
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 186 Issue 7 Pg. 4331-9 (Apr 01 2011) ISSN: 1550-6606 [Electronic] United States
PMID21357542 (Publication Type: Journal Article, Research Support, American Recovery and Reinvestment Act, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Antibodies, Viral
  • Immunoglobulin G
  • Influenza Vaccines
  • NP protein, Influenza A virus
  • Nucleocapsid Proteins
  • RNA-Binding Proteins
  • Viral Core Proteins
Topics
  • Animals
  • Antibodies, Viral (biosynthesis, blood, physiology)
  • Antibody Diversity (immunology)
  • Humans
  • Immunoglobulin G (biosynthesis, blood, physiology)
  • Influenza A Virus, H1N1 Subtype (immunology)
  • Influenza A Virus, H3N2 Subtype (immunology)
  • Influenza A virus (immunology)
  • Influenza Vaccines (administration & dosage, biosynthesis, blood)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Mutant Strains
  • Nucleocapsid Proteins
  • Orthomyxoviridae Infections (immunology, mortality, prevention & control)
  • RNA-Binding Proteins (blood, immunology)
  • Viral Core Proteins (blood, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: